Search Results

134 results

  1. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 25

    Misperception of e-cigarette harm growing among American adults, 2013-2015

    VERRON T.(1); GUO M.(1); VARIGNON B.(1); O'CONNELL G.(2); WALELE T.(2); CAHOURS X.(1)
    (1) SEITA - Imperial Brands plc, Paris, France; (2) Fontem Ventures B.V., Amsterdam, The Netherlands
    Electronic cigarettes (e cigarettes) have been characterised as significantly less harmful than smoked tobacco by an increasing number of public health authorities. However, the proportion of American adults who perceive e cigarettes to be equally or more ...
  2. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 38

    Impact of cigarette paper parameters on smoke yields of cigarettes with different circumferences

    MÜLLER P.; GLEINSER M.; BACHMANN S.; VOLGGER D.
    Papierfabrik Wattens GmbH & Co. KG, Wattens, Austria
    Cigarettes with reduced circumference are very popular in several markets. Over the last decade a significant growth rate has been observed worldwide. Changing the circumference has an influence on the physical properties of the unlit cigarette and ...
  3. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 41

    Functional filter wrapping materials and their impacts on specific properties of factory-made cigarettes and heated tobacco products

    LINDNER M.(1); MAIWALD B.(2); DITTOMBEE H.(2); LEICHSENRIGN N.(2)
    (1) TANNPAPIER GmbH, Traun, Austria; (2) Hauni Maschinenbau GmbH, Hamburg, Germany
    Filter wrapping materials are a synonym for mouthpiece covering sheets that include tipping and filter plug wrap paper. Both sheets play an essential role for the manufacturing of conventional filter cigarettes and heated tobacco products (HTP) as they ...
  4. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 36

    Analysis of the TPD2-related flavor compounds in cigarettes by GC-MS/MS and LC-MS/MS

    ORIKATA N.(1); SATO S.(2); TOBITA T.(1); OGAWA T.(1); NINOMIYA M.(1)
    (1) Japan Tobacco Inc., Product Quality Research Center, Yokohama, Kanagawa, Japan; (2) JTI Ökolab, Vienna, Austria
    The new European Union Tobacco Products Directive (TPD2) came into force in May 2016. The European Commission has established a priority list of 15 additives referred to in Article 6 of TPD2. The purpose of this study was to develop quantitative analysis ...
  5. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 37

    Simultaneous determination of sugar alcohols in cigarettes by LC-MS/MS

    OGAWA T.(1); TOBITA T.(1); ORIKATA N.(1); SATO S.(2); NINOMIYA M.(1)
    (1) Japan Tobacco Inc., Product Quality Research Center, Yokohama, Kanagawa, Japan; (2) JTI Ökolab, Vienna, Austria
    Sugar alcohols are used generally and widely as sweeteners and humectants in the food industry. On the other hand, it is known that some sugar alcohols are present in tobacco leaf and tobacco products such as cigarettes. However, there is no method for ...
  6. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 39

    The use of high content screening (HCS) in human primary lung cells to assess e-liquids of differing flavors and nicotine concentrations

    SIMMS L.(1); CZEKALA L.(1); STEVENSON M.(1); PHILLIPS G.(1); WALELE T.(2)
    (1) Imperial Brands, Bristol, U.K.; (2) Fontem Ventures, Amsterdam, The Netherlands
    Due to the current scientific debate and evolving regulatory landscape, new assays are needed to quickly determine the subtle biological response of e-liquids for both stewardship and product development purposes. For stewardship, all ingredients in the e ...
  7. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 41

    LC-MS/MS multi-method for the determination of mono- and dicarbonyls in e-liquid and e-cigarette vapor

    POUR G.; WERNETH M.; KUBA M.; OHASHI S.; MAYER-HELM B.; SCHMEISSER E.
    JTI Ökolab, Vienna, Austria
    It is generally accepted that e-liquids and e-cigarette vapor may contain mono- and dicarbonyls. This class of compounds derive either from propylene glycol, glycerol or flavor substances in e-liquids or from thermal degradation during the vaping process. ...
  8. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 52

    Biological test procedure for fresh generated cigarette smoke and e-cigarette aerosols under air-liquid interface (ALI) exposure in 24 and 96 multi-well plates

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    Cigarette smoke and e cigarette aerosol contain particulate matter/liquid droplets in the solid phase as well as volatile substances in the gas phase. Both fractions are of potential toxicological relevance and should be considered when assessing ...
  9. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 53

    Use of human derived cell lines to increase the biological relevance of cigarette condensate, non-tobacco materials and e-liquids testing

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    The in vitro testing strategy of tobacco products is mainly based on the testing of extracts from cigarette smoke condensates. An accepted industry wide assay battery has been developed over recent years which delivers reliable results for the ...
  10. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 58

    Developing fit-for-purpose self-report instruments for assessing consumer responses to tobacco and nicotine products: the ABOUT Toolbox initiative

    CHREA C.(1); SPIES E.(1); AFOLALU E.F.(1); MAINY N.(1); GALLOT S.(1); BINGGELI P.(1); CLERC E.(1); WEITKUNAT R.(1); SALZBERGER T.(2); CANO S.(3); ACQUADRO C.(4); ARNOULD B.(4); LAMBERT J.(4); BRUNEL V.(4); MARCUCCILLI C.(4); ABETZ-WEBB L.(5); ROSE J.(5); FAGERSTRÖM K.(5)
    (1) Philip Morris Products S.A.(part of Philip Morris International group of companies), Neuchâtel, Switzerland; (2) University of Economics and Business, Vienna, Austria; (3) ScaleReport, Ltd, Stotfold, U.K.; (4) Mapi, an ICON plc Company, Lyon, France; (5) Patient-Centered Outcomes Assessments, Ltd, Macclesfield, Cheshire, U.K.; (6) Rose Research Center, Raleigh, NC, U.S.A.; (7) K. Fagerström Consulting AB, Vaxholm, Sweden
    Assessing the full potential of reduced risk products (RRP), for individual users and the population as a whole, requires the assessment of consumer perception and behavior associated with tobacco and nicotine products (TNP) with different exposure and ...